Your browser doesn't support javascript.
loading
Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland.
Brock, Elisabeth; Moschovitis, Giorgio; Maeder, Micha T; Pfister, Otmar.
Affiliation
  • Brock E; Market Access Switzerland/Health Economics Europe, HealthEcon AG, Steinentorstrasse 19, 4051, Basel, Switzerland. ebrock@healthecon.com.
  • Moschovitis G; Division of Cardiology, Regional Hospital of Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
  • Maeder MT; Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Pfister O; Cardiology Department, University Hospital Basel, Basel, Switzerland.
Pharmacoecon Open ; 6(5): 735-743, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35687248
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Health_economic_evaluation Language: En Journal: Pharmacoecon Open Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Health_economic_evaluation Language: En Journal: Pharmacoecon Open Year: 2022 Document type: Article Affiliation country: Country of publication: